Encompass Health 3Q 2026: Revenue $1.61B, EPS $1.5— 10-Q Summary

What happened

Encompass Health reported third-quarter 2026 revenue of $1.61 billion, up 8.9% from a year earlier. Net income rose 16.6% to $203.6 million, and diluted earnings per share, or profit allocated to each share, increased 21% to $1.50. Higher patient volumes and pricing mainly supported growth.

Confirmed

Global impact / market context

Higher patient volumes and pricing lifted revenue, while net income grew faster than revenue, suggesting improved profit per sale during the quarter. Continued growth could support the company’s ability to fund hospital and bed expansion, though the article gives no cost or cash-flow details.

Analyst inference

Higher patient volumes and pricing supported Encompass Health’s reported revenue growth, while its planned hospital and bed expansion could add capacity to meet expected demand. The higher Medicare revenue share may also change the company’s exposure to different payment sources, but the article gives no resulting cost or profit outlook.

Analyst inference

What to watch

1. Check whether discharge growth continues and whether the company reports further detail on pricing and patient volumes, the two factors identified as supporting quarterly revenue growth. Analyst inference
2. Track announced hospital openings and bed additions through 2027, since expansion requires added capacity and could affect future costs and revenue as facilities fill. Proposed
3. Watch whether Medicare and Medicare Advantage shares keep moving in opposite directions; the article reports the quarter’s mix but gives no outlook for either payer. Analyst inference

Evidence

• Original source link unavailable